PA
ANGO icon

Parallel Advisors’s AngioDynamics ANGO Stock Holding History

Parallel Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Buy
+1,389
New +$15.8K ﹤0.01% 2665
2023
Q4 		– Sell
-72
Closed -$526 – 3321
2023
Q3 		$526 Hold
72
– – ﹤0.01% 3097
2023
Q2 		$751 Buy
72
+17
+31% +$164 ﹤0.01% 3002
2023
Q1 		$569 Sell
55
-70
-56% -$896 ﹤0.01% 3080
2022
Q4 		$1.72K Buy
125
+32
+34% +$445 ﹤0.01% 2740
2022
Q3 		$2K Hold
93
– – ﹤0.01% 2580
2022
Q2 		$2K Hold
93
– – ﹤0.01% 2529
2022
Q1 		$2K Sell
93
-57
-38% -$1.29K ﹤0.01% 2541
2021
Q4 		$4K Hold
150
– – ﹤0.01% 2453
2021
Q3 		$4K Hold
150
– – ﹤0.01% 2426
2021
Q2 		$4K Hold
150
– – ﹤0.01% 2342
2021
Q1 		$4K Hold
150
– – ﹤0.01% 2237
2020
Q4 		$2K Hold
150
– – ﹤0.01% 2263
2020
Q3 		$2K Hold
150
– – ﹤0.01% 2264
2020
Q2 		$1K Hold
150
– – ﹤0.01% 2284
2020
Q1 		$1K Buy
+150
New +$1.88K ﹤0.01% 2225

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parallel Advisors's ANGO Position: Q2 2026 in Review

Parallel Advisors opened a new position in AngioDynamics (ANGO) in Q2 2026: 1,389 shares worth $18.1K. The stake represents ﹤0.01% of the portfolio and ranks #2665 among its holdings. This is a return to the name: Parallel Advisors previously reported a position in ANGO as recently as Q3 2023.

Parallel Advisors first reported a position in ANGO in Q1 2020 and has held it in 16 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Parallel Advisors held 1,389 shares of AngioDynamics worth $18.1K as of Q2 2026.
  • AngioDynamics was a new Parallel Advisors position in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2665 holding.
  • Parallel Advisors first reported a position in AngioDynamics in Q1 2020 and has held it in 16 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.